Vince Martin

Vince Martin

InvestorPlace Contributor

Vince Martin has written investing advice for several years, covering stocks across a range of industries. A former registered representative, Martin saw the dot-com bubble inflate and burst in real time, creating a healthy respect for downside risk. He splits his time between Chicago and rural Wisconsin with his wife and three dogs.

Recent Articles

3 Reasons Sprint Corp (S) Stock Has Even MORE Upside

By Vince Martin, InvestorPlace Contributor

Sprint stock has flattened out in 2017 after torrid gains last year. But S stock still has plenty of catalysts to drive more upside as the year plays out.

Why Teva Pharmaceutical Industries Ltd (ADR) Stock Has Staying Power

By Vince Martin, InvestorPlace Contributor

After a rough few years for TEVA stock, it has become too cheap to ignore. There are risks, but are several reasons to go long Teva Pharma stock.

Why Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Only Getting Worse

By Vince Martin, InvestorPlace Contributor

Bill Ackman's exit doesn't mark the end of the decline for VRX stock. Rather, it's a warning about where Valeant stock is heading.

Why Nvidia Corporation (NVDA) Is a Big, Fat Question Mark Right Now

By Vince Martin, InvestorPlace Contributor

NVDA stock has rebounded in part due to optimism after the Intel-Mobileye deal. But that deal provides challenges for Nvidia as well.

Trump’s EPA Policies Could Help Ford Motor Company (F) and General Motors Company (GM)

By Vince Martin, InvestorPlace Contributor

A loosening of environmental regulations by Trump -- including a change to California's waiver -- could help General Motors and Ford stock.

Load More